Litigator of the Week Runners-Up and Shout-Outs
Runners-up this week include litigation teams at Wilmer and Kirkland.
October 18, 2024 at 07:25 AM
6 minute read
First up this week is a team at Wilmer Cutler Pickering Hale and Dorr that helped pharmaceutical client Exelixis Inc. protect the validity of the patents underlying Cabometyx and Cometriq, two drugs to treat kidney, liver and thyroid cancers that generated about $1.6 billion in sales in 2023. The case came in the context of MSN Pharmaceuticals Inc. seeking approval of a generic version of Cabometyx. After a four-day bench trial last October, U.S. District Senior Judge Richard Andrews in Delaware this week sided with Exelixis on the validity of three patents that MSN stipulated its proposed generic version infringed upon. The judge found a fourth patent valid, but not infringed. The Wilmer team includes Bill Lee, Lisa Pirozzolo, Emily Whelan, Kevin Prussia, Marissa Lalli, Jonathan Cox and Timothy Cook.
NOT FOR REPRINT
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
You Might Like
View AllA Couple of Early Suggestions From ABOTA's 'A More Perfect Jury' Project
A Reporter and a Mayor: Behind the Scenes During the Eric Adams Indictment News Cycle
Trending Stories
- 1The Law Firm Disrupted: Playing the Talent Game to Win
- 2A&O Shearman Adopts 3-Level Lockstep Pay Model Amid Shift to All-Equity Partnership
- 3Preparing Your Law Firm for 2025: Smart Ways to Embrace AI & Other Technologies
- 4BD Settles Thousands of Bard Hernia Mesh Lawsuits
- 5A RICO Surge Is Underway: Here's How the Allstate Push Might Play Out
Featured Firms
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250